The future of CTCL therapy
2 Bekeken
• 08/09/23
0
0
insluiten
administrator
abonnees
Julia Jane Scarisbrick, MBChB, FRCP, MD, University Hospital Birmingham, Birmingham, UK, shares her views on the future of cutaneous T-cell lymphoma (CTCL) therapy, highlighting the unmet need for more efficacious therapies and to determine the optimal sequencing of therapies. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties